Skip to content

Molecular Diagnosis and Prognosis of Ductal Carcinoma In Situ (DCIS)

A novel molecular marker that provides a reliable prognostic indicator for DCIS breast cancer patients

Published: 28th July 2022
Molecular Diagnosis and Prognosis of Ductal Carcinoma In Situ (DCIS)
Source: David A Litman, https://stock.adobe.com/uk/301030167, stock.adobe.com
IP Status
  • Patented
Seeking
  • Licensing